Podcasts about medipharm labs

Third quarter 2021 earnings call for MediPharm Labs Corp. For further information, please consult the company website at https://www.medipharmlabs.com/Support this podcast at — https://redcircle.com/tsx-quarterly/exclusive-contentAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Second quarter 2021 earnings call for MediPharm Labs Corp. For further information, please consult the company website at https://www.medipharmlabs.com/Support this podcast at — https://redcircle.com/tsx-quarterly/exclusive-contentAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

First quarter 2021 earnings call for MediPharm Labs Corp. For further information, please consult the company website at https://www.medipharmlabs.com/ Support this podcast at — https://redcircle.com/tsx-quarterly/exclusive-content Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy

We talk about the latest quarterlies of High Tide, Aleafia, Medipharm Labs, Trulieve, Curaleaf, Cresco Labs and Green Thumb. We then discuss the growing trend of press releasing financials and holding a conference call before releasing financials. We finish by going over New York legalization and the current landscape of biosynthesis. 

Fourth quarter 2020 earnings call for MediPharm Labs Corp. For further information, please consult the company website at https://www.medipharmlabs.com/ Support this podcast at — https://redcircle.com/tsx-quarterly/exclusive-content Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy

Third quarter 2020 earnings call for MediPharm Labs Corp. For further information, please consult the company website at https://www.medipharmlabs.com/ Support this podcast at — https://redcircle.com/tsx-quarterly/exclusive-content Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy

Second quarter 2020 earnings call for MediPharm Labs Corp. For further information, please consult the company website at https://www.medipharmlabs.com/ Support this podcast at — https://redcircle.com/tsx-quarterly/exclusive-content Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy

First quarter 2020 earnings call for MediPharm Labs Corp. For further information, please consult the company website at https://www.medipharmlabs.com/ Support this podcast at — https://redcircle.com/tsx-quarterly/exclusive-content Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy

This week's episode saw Pat McCutcheon, the Co-Founder, CEO & Chairman of MediPharm Labs join Jonny and Oscar on the pod. Following Medipharm's recent partnership with a pharma giant and drawing from 15 years experience working directly within the pharmaceutical industry, Pat is the perfect person to give insights on how cannabusinesses can transition into the medical market. 

On today's show we're joined by Dr. Markus Roggen CEO of Complex Biotech Discovery Ventures (CBDVL) - licensed cannabis research and development firm focusing on cannabis extraction optimisation, analytical testing, and chemical process development.Join us as we dive into the chemistry of cannabis, including the different ways in which cannabinoids can be extracted, why the ‘entourage effect' needs to be redefined, and the role of fundamental cannabis research.→ View full show notes and summary here: https://www.cannabis-conversation.com/blogs/episode89About Dr. Markus RoggenDr. Markus Roggen's latest project, Complex Biotech Discovery Ventures, is a fundamental research laboratory and CRO for the cannabis and hemp industries. His research interests lie in the metabolite composition and behavior throughout the production cycle, extraction optimisation, and development of innovative therapeutic formulations. Dr. Roggen received his M/Sci degree from Imperial College, London, UK in 2008. He then pursued his graduate degree in organic chemistry at the Federal Institute of Technology in Zürich (ETHZ), where he received his PhD in 2012. Dr. Roggen was awarded an DAAD postdoctoral fellowship to pursue further training in physical organic chemistry at The Scripps Research Institute in La Jolla from 2013-2014. He then entered the cannabis industry, at first as laboratory director for Davinci Laboratories of California, an analytical laboratory from 2014 to 2016. In 2016, he moved into an executive position overseeing production, R&D and process optimisation for OutCo, a vertically integrated cannabis company. Dr. Roggen is also a trusted advisor and mentor to multiple startups, startup accelerators and organisations. Positions include advisory positions at Bloom Automation, a cannabis robotics company, and former SAB member at MediPharm Labs, a Canadian LP, and co-chair of the NCIA Scientific Advisory Committee.ResourcesFollow CBDVL on LinkedIn: www.linkedin.com/company/cbdvlJoin Dr. Markus Roggen on LinkedIn: https://www.linkedin.com/in/markus-roggen-13a9b286/Complex Biotech Discovery Ventures Website: https://cbdvl.com/Why Is THCA Decarboxylation Faster than CBDA? Paper: https://cbdvl.com/article-why-is-thca-decarboxylation-faster-than-cbda/

Reefer Reporters Thursday Edition with Kim Cooper & GreenIrene September 24th 2020 Today's stories include:Canna-based packaging, THC researched to prevent ARDS, CBD researched to treat anxiety, Kelowna's record breaking harvest, No revenue sharing in BC according to municipalities, Thefts rise amidst harvest season, Thoughtful Brands (formerly MOTA) buys Kentucky CBD company, First CBD cafe opens in Hong Kong, Paraguay & South America's evolving cannabis laws, Medipharm Labs enters Brazilian market

Today's interview is with Sybil Taylor, who is a seasoned marketer with well over 20 years in the alcohol & now the cannabis space. Sybil is currently the Chief Marketing Officer for Medipharm Labs, she talks about her professional life & why her approach to marketing over the years has found success. I've personally admired her work on social streams for about 3 years, trust me, she's really good! If you're a marketer, in sales, communications, or whatever.. This one's for you! Find Sybil on LinkedIn: https://www.linkedin.com/in/sybil-taylor/

We had the chance to chat with Keith Strachan, President & Co-Founder of MediPharm Labs on The Shake Podcast, Powered by Treehouse Solution. We took the opportunity to discuss his education, what made him pivot into the cannabis industry alongside highlighting some of their key milestone achievements. Keith Discusses the impacts that the latest list of essential services has had on MediPharm Labs, Branded Products, GMP Certification as well as strategic agreements. We'll also get a better understanding of their global footprint and what they've done to create on elf the top brands in the cannabis industry. www.medipharmlabs.com www.treehousesolution.com

Treehouse Solution Content Media Platform presents "The Shake", a Podcast on Cannabis : Join the discussion with Sybil Taylor, Chief Marketing Officer at Medipharm Labs. MediPharm Labs are the leaders in cannabis extraction services and purification. They've invested in an expert team, state-of-the-art technology, advanced methodologies and a purpose-built facility. Medipharm Lab's goal as one of the top cannabis extraction companies is to deliver pure, trusted and precisely-dosed cannabis concentrates and advanced derivative products. www.treehousesolution.com

Tune in to Episode 47 of Lit & Lucid podcast to hear from Keith Strachan, President & Director of MediPharm Lab Corps in Canada. Keith discusses the current legal cannabis market in Canada, as well as explains the drive behind MediPharm Labs and his interest in cannabis. MediPharm Labs is a leader in cannabis extraction and purification, offering state-of-the-art technology, advanced methodologies and a purpose-built facility to deliver pure, safe and precisely-dosed cannabis concentrates and advanced derivative products. They were recently named the Canadian Cannabis Start up of the year in 2018. Streaming now on iTunes, Anchor.fm, and Spotify. --- Support this podcast: https://anchor.fm/lit-and-lucid/support

Patrick James McCutcheon, the Founder, CEO and Chairman of MediPharm Labs Corporation (OTCQB: MLCPF) chats with us about the company's focus on cannabis oil extraction. 

Get the latest update on Medipharm Labs & the extraction business! Co-Founder Keith Strachan walks us through his world, provides perspective & tells the story of MediPharm's humble beginnings. He's a solid guy & a great communicator. I hope you enjoy :)

Get the latest update on Medipharm Labs & the extraction business! Co-Founder Keith Strachan walks us through his world, provides perspective & tells the story of MediPharm's humble beginnings. He's a solid guy & a great communicator. I hope you enjoy :)

Pat McCutcheon, Ceo of MediPharm Labs speaks candidly about his company and their impending IPO on Oct 3rd 2018. Extractions are expected to be the second wave in cannabis legalization, find out why Pat claims MediPharm Labs is positioned to lead the pack! Enjoy :)

This week guest hosts Elliot Lane and Tony Noto interview Bryan Passman of Hunter +Esquire and The GIGG, Pat McCutcheon from MediPharm and Peter Schippen of Britannia Life Sciences. * Bryan Passman* is the co-founder of the cannabis industry executive search firm and consultancy Hunter + Esquire, as well as the staffing agency The GIGG® which also exclusively serves the cannabis industry. Bryan has spent his entire career succeeding in retained executive search - with a foundation of classical training by the MRINetwork and Dale Carnegie. Before co-founding Hunter + Esquire and The GIGG®, Bryan spent nearly 20 years as an SVP Recruitment and Client Leader at two different well-known search agencies where he and his teams were responsible for successfully managing talent searches globally. Bryan is internationally renowned in executive search and advisory in the Cannabis, MedTech/ Pharma/Biotech, and Food & Beverage (FMCG) Consumer Packaged Goods industries. Clients have included small and large U.S. and International Cannabis companies, hundreds of startup and blue chip companies in the Healthcare life sciences and (food and adult beverage) Consumer Packaged Goods industries in every imaginable corner of the world, as well Tech and Packaging companies serving the CPG and Hospitality industries. *Pat McCutcheon* , Chief Executive Officer and Chairman Before founding MediPharm Labs, Pat enjoyed a 15-year career in the pharmaceutical industry in top sales roles, successfully launching a wide range of medical products. He most recently worked at Janssen Pharmaceuticals (Johnson & Johnson) where he led the Hospital Division for Renal and Mental Health products. Pat's foresight in creating a business that focuses on advanced cannabis concentrates bodes well for medical research, investors and consumers alike. Pat holds an HBSc (Biology) degree from the University of Western Ontario. *Peter Schippen* is a British-born entrepreneur, best known for his work in the Canadian financial services industry, where he founded a business that he grew and ultimately sold to Purpose Investments. Peter spent 7 years working in Canadian banking, in investment research, holding increasingly senior positions at Bank of Montreal and TD Bank. In 2007, Peter acquired a company that would eventually become Redwood Asset Management. Under his tenure, AUM grew steadily despite market challenges, and was acquired by Purpose Investments in 2016.  As an  early investor in the Canadian cannabis market, Peter was involved in the conception the Medical Cannabis and Wellness ETF that is listed on the LSE under CBDX. Peter is a CFA Charterholder, CAIA Charterholder and recently received his ICD designation through the Institute for Corporate Directors and the University of Toronto. Peter completed his undergraduate degree in economics at Wilfrid Laurier University.